Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Serum Institute of India Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Serum Institute of India Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Serum Institute of India Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Serum Institute of India Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Serum Institute of India Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Serum Institute of India Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Serum Institute of India Ltd, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Serum Institute of India Acquires Production Facilities Of Netherlands Vaccine Institute For US$40 Million 12
Venture Financing 13
Visterra Raises Additional USD23.6 Million in Series C Financing 13
Private Equity 15
Serum Institute Plans to Sell Minority Stake in Itself 15
Partnerships 16
Serum Institute of India Enters into Licensing Agreement with St. Jude Children’s Research Hospital 16
IAVI and Serum Institute of India Enter into Development Partnership 17
Panacea Biotec Enters into Agreement with Serum Institute of India 18
Cipla Enters into Distribution Agreement with Serum Institute 19
Cipla Enters into Distribution Agreement with Serum Institute of India 20
Licensing Agreements 21
Serum Institute of India Enters into Licensing Agreement with Visterra 21
Serum Institute Expands Licensing Agreement with Genkyotex 22
Genticel Enters into Licensing Agreement with Serum Institute of India 23
Serum Institute of India Enters into Licensing Agreement with NeuClone 24
Nanolek Enters into Licensing Agreement with Bilthoven Biologicals for IPV Vaccine 25
Serum Institute of India Enters Into Licensing Agreement With Vakzine Projekt Management For VPM1002 26
Equity Offering 27
Xenetic Biosciences Raises USD0.3 Million in Private Placement of Shares 27
Acquisition 28
Serum Institute of India Acquires Nanotherapeutics for USD78.2 Million 28
Serum Institute Of India Acquires Bilthoven Biologicals, Monoclonal Antibodies And Vaccine Maker, For US$101 Million 29
Serum Institute Plans To Sell Its Stake In Akorn 30
Serum Institute of India Ltd – Key Competitors 32
Serum Institute of India Ltd – Key Employees 33
Serum Institute of India Ltd – Locations And Subsidiaries 34
Head Office 34
Other Locations & Subsidiaries 34
Recent Developments 35
Product News 35
May 24, 2018: Serum Institute To Develop vaccine to fight Nipah Virus 35
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36
Serum Institute of India Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Serum Institute of India Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Serum Institute of India Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Serum Institute of India Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Serum Institute of India Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Serum Institute of India Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Serum Institute of India Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Serum Institute of India Acquires Production Facilities Of Netherlands Vaccine Institute For US$40 Million 12
Visterra Raises Additional USD23.6 Million in Series C Financing 13
Serum Institute Plans to Sell Minority Stake in Itself 15
Serum Institute of India Enters into Licensing Agreement with St. Jude Children’s Research Hospital 16
IAVI and Serum Institute of India Enter into Development Partnership 17
Panacea Biotec Enters into Agreement with Serum Institute of India 18
Cipla Enters into Distribution Agreement with Serum Institute 19
Cipla Enters into Distribution Agreement with Serum Institute of India 20
Serum Institute of India Enters into Licensing Agreement with Visterra 21
Serum Institute Expands Licensing Agreement with Genkyotex 22
Genticel Enters into Licensing Agreement with Serum Institute of India 23
Serum Institute of India Enters into Licensing Agreement with NeuClone 24
Nanolek Enters into Licensing Agreement with Bilthoven Biologicals for IPV Vaccine 25
Serum Institute of India Enters Into Licensing Agreement With Vakzine Projekt Management For VPM1002 26
Xenetic Biosciences Raises USD0.3 Million in Private Placement of Shares 27
Serum Institute of India Acquires Nanotherapeutics for USD78.2 Million 28
Serum Institute Of India Acquires Bilthoven Biologicals, Monoclonal Antibodies And Vaccine Maker, For US$101 Million 29
Serum Institute Plans To Sell Its Stake In Akorn 30
Serum Institute of India Ltd, Key Competitors 32
Serum Institute of India Ltd, Key Employees 33
Serum Institute of India Ltd, Other Locations 34
Serum Institute of India Ltd, Subsidiaries 34
List of Figures
Serum Institute of India Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Serum Institute of India Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Serum Institute of India Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Serum Institute of India Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Serum Institute of India Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Serum Institute of India Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Serum Institute of India Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Serum Institute of India Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Serum Institute of India Ltd, Medical Devices Deals, 2012 to YTD 2018 9